BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15968099)

  • 1. Identification of clonotypic IgH VDJ sequences in multiple myeloma.
    Taylor BJ; Kriangkum J; Strachan ER; Wizniak J; Pilarski LM
    Methods Mol Med; 2005; 113():121-44. PubMed ID: 15968099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease.
    Pilarski LM; Giannakopoulos NV; Szczepek AJ; Masellis AM; Mant MJ; Belch AR
    Clin Cancer Res; 2000 Feb; 6(2):585-96. PubMed ID: 10690543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction.
    Szczepek AJ; Seeberger K; Wizniak J; Mant MJ; Belch AR; Pilarski LM
    Blood; 1998 Oct; 92(8):2844-55. PubMed ID: 9763569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraclonal homogeneity of clonotypic immunoglobulin M and diversity of nonclinical post-switch isotypes in multiple myeloma: insights into the evolution of the myeloma clone.
    Taylor BJ; Pittman JA; Seeberger K; Mant MJ; Reiman T; Belch AR; Pilarski LM
    Clin Cancer Res; 2002 Feb; 8(2):502-13. PubMed ID: 11839670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences.
    Kriangkum J; Taylor BJ; Treon SP; Mant MJ; Reiman T; Belch AR; Pilarski LM
    Clin Cancer Res; 2007 Apr; 13(7):2005-13. PubMed ID: 17404080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin genes in multiple myeloma: expressed and non-expressed repertoires, heavy and light chain pairings and somatic mutation patterns in a series of 101 cases.
    Hadzidimitriou A; Stamatopoulos K; Belessi C; Lalayianni C; Stavroyianni N; Smilevska T; Hatzi K; Laoutaris N; Anagnostopoulos A; Kollia P; Fassas A
    Haematologica; 2006 Jun; 91(6):781-7. PubMed ID: 16769580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34+ cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangements.
    Szczepek AJ; Bergsagel PL; Axelsson L; Brown CB; Belch AR; Pilarski LM
    Blood; 1997 Mar; 89(5):1824-33. PubMed ID: 9057669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescent polymerase chain reaction and capillary electrophoresis for IgH rearrangement and minimal residual disease evaluation in multiple myeloma.
    Novella E; Giaretta I; Elice F; Madeo D; Piccin A; Castaman G; Rodeghiero F
    Haematologica; 2002 Nov; 87(11):1157-64. PubMed ID: 12414345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive detection using microfluidics technology of single cell PCR products from high and low abundance IgH VDJ templates in multiple myeloma.
    Pilarski LM; Lauzon J; Strachan E; Adamia S; Atrazhev A; Belch AR; Backhouse CJ
    J Immunol Methods; 2005 Oct; 305(1):94-105. PubMed ID: 16150455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a unique Ig heavy-chain isotype (IgT) in rainbow trout: Implications for a distinctive B cell developmental pathway in teleost fish.
    Hansen JD; Landis ED; Phillips RB
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6919-24. PubMed ID: 15863615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible mechanism of inability of immunoglobulin heavy-chain production in Bence-Jones type myeloma cells.
    Sakai A; Kawano MM; Tanabe O; Kuramoto A
    Int J Hematol; 1993 Dec; 59(1):31-40. PubMed ID: 8161734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of malignant cells in multiple myeloma bone marrow with immunoglobulin VH gene probes by fluorescent in situ hybridization and flow cytometry.
    Cao J; Vescio RA; Hong CH; Kim A; Lichtenstein AK; Berenson JR
    J Clin Invest; 1995 Mar; 95(3):964-72. PubMed ID: 7883997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clonal origin of the myeloma cells secreting three kinds of immunoglobulin from a multiple myeloma patient].
    Zhu P; Liu J; Lin N
    Zhonghua Xue Ye Xue Za Zhi; 2001 Nov; 22(11):577-80. PubMed ID: 11855145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile of immunoglobulin heavy chain variable gene repertoires and highly selective detection of malignant clonotypes in acute lymphoblastic leukemia.
    Greenberg SJ; Choi Y; Ballow M; Du TL; Ward PM; Rickert MH; Frankel S; Bernstein SH; Brecher ML
    J Leukoc Biol; 1995 Jun; 57(6):856-64. PubMed ID: 7790768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of clonotypic switch junctions reveals multiple myeloma originates from a single class switch event with ongoing mutation in the isotype-switched progeny.
    Taylor BJ; Kriangkum J; Pittman JA; Mant MJ; Reiman T; Belch AR; Pilarski LM
    Blood; 2008 Sep; 112(5):1894-903. PubMed ID: 18577707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
    Pilarski LM; Seeberger K; Coupland RW; Eshpeter A; Keats JJ; Taylor BJ; Belch AR
    Exp Hematol; 2002 Mar; 30(3):221-8. PubMed ID: 11882359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of tumor specific immunoglobulin gene rearrangement in peripheral blood B-cells of multiple myeloma patients by a PCR-SSCP method.
    Wu S; Wang L; Wang Y; Zhu P; Xie G
    Chin Med J (Engl); 1997 Sep; 110(9):682-5. PubMed ID: 9642324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative polymerase chain reaction analysis with allele-specific oligonucleotide primers for individual IgH VDJ regions to evaluate tumor burden in myeloma patients.
    Sata H; Shibayama H; Maeda I; Habuchi Y; Nakatani E; Fukushima K; Fujita J; Ezoe S; Tadokoro S; Maeda T; Mizuki M; Kosugi S; Nakagawa M; Ueda S; Iida M; Tokumine Y; Azenishi Y; Mitsui H; Oritani K; Kanakura Y
    Exp Hematol; 2015 May; 43(5):374-381.e2. PubMed ID: 25591497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of malignant plasma cells by mRNA in situ hybridization.
    Brown RD; Ho PJ
    Methods Mol Med; 2005; 113():175-81. PubMed ID: 15968102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of minimal residual disease in multiple myeloma by fluorescent molecular beacons in real time PCR of IgH gene rearrangements and correlation with flow cytometry.
    Kara IO; Duman BB; Afsar CU
    J BUON; 2013; 18(2):442-7. PubMed ID: 23818359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.